Publication:
Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.

dc.contributor.coauthorTural, Deniz
dc.contributor.coauthorArslan, Cagatay
dc.contributor.coauthorOlmez, Omer Fatih
dc.contributor.coauthorAkar, Emre
dc.contributor.coauthorErman, Mustafa
dc.contributor.coauthorUrun, Yuksel
dc.contributor.coauthorErdem, Dilek
dc.contributor.coauthorKilickap, Saadettin
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorSelçukbiricik, Fatih
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2025-01-19T10:34:25Z
dc.date.issued2023
dc.description.indexedbyWOS
dc.description.issue6
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume41
dc.identifier.eissn1527-7755
dc.identifier.issn0732-183X
dc.identifier.quartileN/A
dc.identifier.urihttps://hdl.handle.net/20.500.14288/26768
dc.identifier.wos1098050200510
dc.language.isoeng
dc.publisherLippincott Williams and Wilkins
dc.relation.ispartofJournal of Clinical Oncology
dc.subjectOncology
dc.titleComparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.kuauthorSelçukbiricik, Fatih
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files